Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05202782
Title Zanubrutinib and CAR T-cell Therapy for the Treatment of Recurrent or Refractory Aggressive B-cell Non-Hodgkin's Lymphoma or Transformed Indolent B-cell Lymphoma
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Northwestern University
Indications

non-Hodgkin lymphoma

diffuse large B-cell lymphoma

B-cell lymphoma

diffuse large B-cell lymphoma activated B-cell type

diffuse large B-cell lymphoma germinal center B-cell type

primary mediastinal B-cell lymphoma

Therapies

Zanubrutinib

Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
Northwestern University Recruiting Chicago Illinois 60611 United States Details
Medical College of Wisconsin Not yet recruiting Milwaukee Wisconsin 53226 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field